Global Compliance partner Brian Burke spoke on the “Global Compliance ― Emerging Markets and Third-Party Due Diligence” panel at the Pharmaceutical Compliance Congress in Washington, D.C. on April 24, 2018.

Other industry thought leaders participating on this panel included:

• David Styler
  Head, Global Compliance Governance and Investigations
  Takeda Pharmaceuticals
• Gildas Durand
  Principal, Fraud Investigations & Dispute Services
  Ernst & Young LLP
• Richard Wright
  Vice President, Global Head of Compliance Audit
  Teva Pharmaceuticals

Discussion topics included:

• Assess how vendors are interacting, in the marketplace, on your behalf
• Navigate the specialty marketplace and educate third parties on the complexities of marketing, selling and distributing these products
• Review strategies for effective oversight, both locally and globally
• Identify controls to minimize risk through distributors, high-risk parties and complex business transactions
• Monitor relationships with specialty pharmacies and distributors
• Ensure third parties remain compliant
• Assess what controls should be in place
• Discuss strategies for ensuring contracting compliance
• Examine sub-distributors, auditing facilities and audit provisions